¡Hola, gente! Del 15 de septiembre al 16 de octubre es Mes Nacional de la Herencia Hispana. Y para conmemorarlo, tendremos una serie especial de episodios del podcast del ACVP, A Conversation in Veterinary Pathology — Una conversación en patología veterinaria. Nos acompañarán invitados e invitadas especiales para compartir sus experiencias, trayectorias y perspectivas dentro del mundo de la patología veterinaria. Súmense, y escúchanos en tu plataforma de podcasts favorita. ____ ACVP Social

Neuroscience Daily for 30 September follows 3 stories from r/neuro and r/neuroscience, moving through brain aging mri, locus coeruleus taste, predictive learning.Chapters 00:00:00 — Intro 00:00:11 — Brain Aging MRI 00:01:22 — Locus Coeruleus Taste 00:02:25 — Predictive Learning 00:03:40 — Closing 1. Brain Aging MRI Brain scans reveal which disorders are linked to faster brain aging, according to ScienceDaily’s report on a PLOS Medicine study. Researchers compared structural MRI data

Nine major European drugmakers warn the region risks losing pharma investment, Novartis licenses a preclinical radioligand therapy asset from BoomRay Pharmaceuticals, and Rafaat Rahmani argues that the costliest competitive intelligence failure is missing the moment a strategic assumption goes wrong.

In today's ACT Brief, we examine what AI simulations surface in trial design, how RBQM delivers measurable financial returns, and three new FDA-approved treatments across hair loss, movement disorder, and bone disease.

في هذا الفيديو، تدخل إيناس شهرها التاسع من الحمل، مع اقتراب موعد الولادة وبدء الاستعدادات للمرحلة الأخيرة. 🤰👶❤️‍🔥 كما يتناول الفيديو موضوع التأمين الصحي للأم والطفل في ألمانيا، وسط أجواء من الترقب والاستعداد للولادة. 🇩🇪🔥تابعوا الفيديو لمعرفة آخر التفاصيل حول الحمل، موعد الولادة والاستعدادات الصحية للأم والطفل. 👀❤️

In today's ACT Brief, we examine how AI is surfacing endpoint options beyond traditional design thinking, why sponsor oversight of outsourced work often fails on inspection despite being robust in practice, and a new combination drug for advanced kidney cancer.

🔥❤️ في هذا الفيديو، يظهر موزو وهو يتفاعل مع إيناس في أجواء عفوية ومليئة بالمرح والضحك. 😍😂 ويبدو أن الحديث يدور حول موقف طريف ومفاجئ أثار تفاعلًا كبيرًا بينهما. 👀✨🥰 تابعوا الفيديو حتى النهاية لمعرفة تفاصيل الموقف وردود الفعل!👍 لا تنسوا الإعجاب، 💬 التعليق، 📲 المشاركة، والاشتراك في القناة 🔔❤️

Neuroscience Daily for 27 September follows 3 stories from r/neuro and r/neuroscience, moving through childhood epilepsy, riluzole and glia, brain as computer.Chapters 00:00:00 — Intro 00:00:10 — Childhood Epilepsy 00:01:12 — Riluzole And Glia 00:02:16 — Brain As Computer 00:03:08 — Closing 1. Childhood Epilepsy This story is about how human brain organoids are revealing a possible cause of childhood epilepsy, in a study published by Nature. Researchers modeled tuberous sclerosis

Neuroscience Daily for 26 September follows 3 stories from r/neuro and r/neuroscience, moving through southern europe neurotech, epilepsy astrocytes, amygdala cell map. Chapters 00:00:00 — Intro 00:00:13 — Southern Europe Neurotech 00:01:09 — Epilepsy Astrocytes 00:02:12 — Amygdala Cell Map 00:03:12 — Closing 1. Southern Europe Neurotech The first story is a new map of neurotechnology companies in Spain, Portugal, and Italy, shared through the Neurotech Newsletter. The survey counts 63

FDA approves Ultragenyx's Fayuvi as the first treatment for Sanfilippo syndrome type A, Lisata Therapeutics acquires Marea Therapeutics as mAbxience partners with Sandoz on a hemophilia A biosimilar, and Joe Cunningham argues that executive drug-pricing deals alone won't fix costs.

In today's ACT Brief, we examine what patient-site relationships need beyond easier technology, how to build defensible rare disease evidence from scratch, and how real-world data and AI improve enrollment screening accuracy.

FDA approves Kerendia as the first new treatment for kidney disease in type 1 diabetes in decades, Novo, Roche, and Aethlon Medical strike major deals and mergers with Orbis Medicines, Dualitas Therapeutics, and North Immunology, and Thani Jambulingam of Saint Joseph's University examines the fight to control the GLP-1 patient journey.

In today's ACT Brief, we examine why defensible trial data depends on traceability and platform ownership, what CGT site readiness requires as therapy moves to community care, and why data harmonization is AI's primary bottleneck.

Introduction to Plagues with Dr. Keith

Want to turn fundamental discoveries into real-world health solutions? In this episode, Dr. Erin Mulvihill, who leads uOttawa's Biochemistry graduate program, explains how the program combines fundamental and translational research, interdisciplinary training, strong infrastructure and close mentorship to prepare graduates for careers in academia, industry, government and health care. Learn more: Biochemistry graduate programs: program information: https://www.uottawa.ca/faculty-medicine/grad...

Novo teams up with Anthropic on AI-driven drug discovery, Sling Therapeutics and Circle Pharma close major financing rounds, and IQVIA's Phil Ford makes the case for reimagining medical content as a loop rather than a pipeline.

In today's ACT Brief, we examine understanding the patient journey from end to end, whether decentralization reduces site burden or just shifts it, and why nine European drugmakers are sounding urgent alarms.

🔥❤️ الحقيقة الكاملة حول موزو وإيناس تظهر في هذا الفيديو! 😱✨ قصة مليئة بالمشاعر والسفر واللقاءات واللحظات المميزة التي تثير فضول المتابعين. 💔🥰👀✨ اكتشفوا جميع تفاصيل هذه القصة وتابعوا آخر المستجدات بين إيناس وموزو.🎥 تابعوا الفيديو حتى النهاية لمعرفة كل التفاصيل!👍 لا تنسوا الإعجاب، 💬 التعليق، 📲 المشاركة، والاشتراك في القناة 🔔❤️

In this episode of STBYM’s The Monstrefact, Robert discusses the Kratt from Estonian folklore…See omnystudio.com/listener for privacy information.